APHB Recent News AmpliPhi to Present at Upcoming
Post# of 11
Posted On: 03/02/2014 4:36:52 PM
APHB Recent News
AmpliPhi to Present at Upcoming Healthcare Conferences Business Wire - Wed Feb 26, 6:30AM CST
Competitor Analysis: Clostridium Difficile Vaccines and Therapeutics M2 - Tue Feb 18, 2:37AM CST
Clostridium Difficile Infections (Clostridium Difficile Associated Disease) - Pipeline Review, H2 2013 Report M2 - Thu Feb 06, 2:49AM CST
AmpliPhi Biosciences Closes $18 Million Private Placement Business Wire - Tue Dec 24, 6:30AM CST
AmpliPhi Biosciences Announces $18 Million Private Placement Business Wire - Mon Dec 16, 6:30AM CST
AmpliPhi Biosciences Announces the Appointment of Baxter Phillips, III, as Vice President of Corporate Strategy and Business Development Business Wire - Wed Nov 13, 7:00AM CST
AmpliPhi Signs Exclusive License With University of Leicester, UK to Develop Bacteriophage Therapies Targeting C. Difficile Business Wire - Wed Oct 16, 6:01PM CDT
AmpliPhi Presents Data on Bacteriophages in the Treatment of Lung Infections in Cystic Fibrosis Business Wire - Wed Aug 07, 11:01PM CDT
Huntingtons Disease Therapeutics - 2013 Global Strategic Business Report M2 - Fri Aug 02, 3:49AM CDT
AmpliPhi Signs Global R&D Agreement with US Army to Develop Bacteriophage Therapies to Treat Resistant Bacterial Infections Business Wire - Mon Jul 01, 6:00AM CDT
AmpliPhi to Present at Upcoming Healthcare Conferences Business Wire - Wed Feb 26, 6:30AM CST
Competitor Analysis: Clostridium Difficile Vaccines and Therapeutics M2 - Tue Feb 18, 2:37AM CST
Clostridium Difficile Infections (Clostridium Difficile Associated Disease) - Pipeline Review, H2 2013 Report M2 - Thu Feb 06, 2:49AM CST
AmpliPhi Biosciences Closes $18 Million Private Placement Business Wire - Tue Dec 24, 6:30AM CST
AmpliPhi Biosciences Announces $18 Million Private Placement Business Wire - Mon Dec 16, 6:30AM CST
AmpliPhi Biosciences Announces the Appointment of Baxter Phillips, III, as Vice President of Corporate Strategy and Business Development Business Wire - Wed Nov 13, 7:00AM CST
AmpliPhi Signs Exclusive License With University of Leicester, UK to Develop Bacteriophage Therapies Targeting C. Difficile Business Wire - Wed Oct 16, 6:01PM CDT
AmpliPhi Presents Data on Bacteriophages in the Treatment of Lung Infections in Cystic Fibrosis Business Wire - Wed Aug 07, 11:01PM CDT
Huntingtons Disease Therapeutics - 2013 Global Strategic Business Report M2 - Fri Aug 02, 3:49AM CDT
AmpliPhi Signs Global R&D Agreement with US Army to Develop Bacteriophage Therapies to Treat Resistant Bacterial Infections Business Wire - Mon Jul 01, 6:00AM CDT
(0)
(0)Armata Pharmaceuticals, Inc. (ARMP) Stock Research Links
Scroll down for more posts ▼